ARTICANZ - Beta (ver 0.9)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - location/QLD/4101-South-Brisbane-Queensland-Children-s-Hospital

Search results

8 trial(s) found.
NCT06208657
NCT05327894
NCT05286801
NCT04759586
NCT04322318
NSW2031 - Randwick - Sydney Children's Hospital (SUSPENDED)2145 - Westmead - The Children's Hospital at Westmead (SUSPENDED)2305 - New Lambton Heights - John Hunter Children's Hospital (SUSPENDED)
VIC3052 - Parkville - Royal Children's Hospital Melbourne (SUSPENDED)3168 - Clayton - Monash Medical Centre (SUSPENDED)
QLD4101 - South Brisbane - Queensland Children's Hospital (SUSPENDED)
SA5006 - North Adelaide - Calvary North Adelaide Hospital, Adelaide Oncology & Haematology (SUSPENDED)
WA6009 - Perth - Perth Children's Hospital (SUSPENDED)
NZNZ.1023 - Grafton - Starship Children's Hospital (SUSPENDED)NZ.8011 - Christchurch - Canterbury District Health Board - Christchurch Hospital Cancer Centre (SUSPENDED)
NCT04293562
NSW2031 - Randwick - Sydney Children's Hospital (SUSPENDED)2145 - Westmead - The Children's Hospital at Westmead (SUSPENDED)
QLD4101 - South Brisbane - Queensland Children's Hospital (SUSPENDED)
WA6009 - Perth - Perth Children's Hospital (SUSPENDED)
NCT03959085
2145 - Westmead - The Children's Hospital at Westmead (SUSPENDED)
SA5006 - North Adelaide - Calvary North Adelaide Hospital, Adelaide Oncology & Haematology (SUSPENDED)
NCT02582697
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital (WITHDRAWN)
3021 - St Albans - Western Health - Sunshine Hospital (WITHDRAWN)
NZ.9016 - Dunedin - Dunedin Hospital (WITHDRAWN)
Filters
PD-1/PD-L1
25%
PI3K-delta
13%
PI3K
13%
PI3Kalpha
13%
mTOR
13%
mTORC1
13%
mTORC2
13%
CD19
13%
PD-L1
13%
TIGIT
13%
CD20
13%
PD-1
13%
AXL
13%
CD33
13%
FLT3
13%
CD22
13%




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.